Related to J&J and Crucell in Advanced Negotiations for €1.75B Acquisition Deal

• WHO Gains Access to Schering-Plough Manufacturing Technology for Flu Vaccines
  
• La Jolla Institute to Test IVT’s Delivery Platform with Infectious Disease Candidates
  
• Sanofi Pasteur's Flu Vaccine Manufacturing Plant Gets FDA Nod
  
• ImmuneRegen Taps University of Pittsburgh Scientist to Work on Preclinical Flu Vaccine
  
• Novartis Vaccines Institute Gets Roughly $7M to Develop Bivalent Typhoid Vaccine
  
• Medicago and Genopole to Set Up Plant in France for Influenza Vaccine Production
  
• Crucell and PATH Malaria Vaccine Program Get Funding to Develop a Prime-Boost Adenoviral Vaccine
  
• Novartis Starts Shipment of Seasonal Flu Vaccine to the U.S.
  
• ImmunoVaccine Technologies Collaborates with Scancell to Advance DNA Vaccine Delivery
  
• Crucell Wins $40.7M NIAID Contract to Develop Human Flu mAbs
  
• FDA Raps J&J's Knuckles over Clinical Trials of Ceftobiprole Antibiotic
  
• Sinovac to Supply Flu Vaccine to Beijing Citizens
  
• Gen-Probe to Pay $60M in Prodesse Buyout
  
• GSK’s Seasonal Flu Vaccine Green-Lighted for Use in Children
  
• Crucell Taps Calmune for Discovery Work in Infectious Diseases
  
• NIAID Commissions GenVec for HIV and Influenza Vaccine Development for $2.6M
  
• PPD and Southern Research Ally on Services for Influenza Research
  
• GSK and Crucell Team Up to Develop a Prime-Boost Malaria Vaccine
  
• GlycoVaxyn and Brigham and Women’s Win $3.4M to Develop S. aureus Vaccine
  
• Virginia Commonwealth Uni to Evaluate Prophylactic CMV Vaccination Strategies with Vical